FDA approves Herceptin biosimilar as US patent expiresThe FDA has approved Amgen and Allergan’s biosimilar of Roche’s Herceptin, just in time for the breast cancer Share XFDA approves Herceptin biosimilar as US patent expireshttps://pharmaphorum.com/news/fda-approves-herceptin-biosimilar-as-us-patent-expires/
Teva expands blood pressure drug recall in the US amid cancer fearsTeva has expanded a recall of losartan potassium tablets after tests revealed a potential human carcinogen in the Share XTeva expands blood pressure drug recall in the US amid cancer fearshttps://pharmaphorum.com/news/teva-expands-blood-pressure-drug-recall-in-the-us-amid-cancer-fears/
GSK makes CRISPR play, funding Doudna lab in CaliforniaGlaxoSmithKline has forged an alliance with two leading CRISPR researchers that will see the creation of a new Share XGSK makes CRISPR play, funding Doudna lab in Californiahttps://pharmaphorum.com/news/gsk-makes-crispr-play-funding-doudna-lab-in-california/
Reimagining commercialisation with AIWe speak to Indegene’s Gaurav Kapoor to find out how he thinks pharma’s sales and marketing model needs Share XReimagining commercialisation with AIhttps://pharmaphorum.com/views-analysis-digital/reimagining-commercialisation-with-ai/
Living with LHON: Sight loss won’t stop James from seeing the worldWhen he was first told he had LHON, a rare genetic disease that would rob him of his Share XLiving with LHON: Sight loss won’t stop James from seeing the worldhttps://pharmaphorum.com/views-analysis-patients/living-with-lhon-sight-loss-wont-stop-james-from-seeing-the-world/
Propeller Health: respiring for successDavid Van Sickle is on a mission to transform treatment for respiratory diseases with the company he co-founded, Share XPropeller Health: respiring for successhttps://pharmaphorum.com/r-d/views-analysis-r-d/propeller-health-respiring-for-success/
NHS England gets commercialNHS England is no longer the new kid on the block, taking up its role in 2013. In Share XNHS England gets commercialhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/nhs-england-commercial-framework-vpas/
Under the skin of innovationLEO’s Innovation Lab is working at arm’s length from the main company to encourage original thinking and develop Share XUnder the skin of innovationhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/leo-innovation-lab-john-zibert-digital/
How digital could transform stakeholder engagementDigital may be upending every aspect of the pharma industry, but many would assume that engagement activities like Share XHow digital could transform stakeholder engagementhttps://deep-dive.pharmaphorum.com/magazine/access-and-commercialisation/impetus-digital-stakeholder-engagement/
Orphan medicines launch excellence: sustaining launch success Share XOrphan medicines launch excellence: sustaining launch successhttps://pharmaphorum.com/market-access-2/orphan-medicines-launch-excellence-sustaining-launch-success/
Navigating new frontiers: Ways to find space in the future RA market Share XNavigating new frontiers: Ways to find space in the future RA markethttps://pharmaphorum.com/r-d/navigating-new-frontiers-ways-to-find-space-in-the-future-ra-market/
The 2nd Life Sciences Sector Deal and the NHS 10 Year Plan Share XThe 2nd Life Sciences Sector Deal and the NHS 10 Year Planhttps://pharmaphorum.com/market-access-2/the-2nd-life-sciences-sector-deal-and-the-nhs-10-year-plan/
A blueprint for healthcare: Brand strategy and planningWhen pharmaceutical and biotech companies are working on their brand strategy and conducting brand planning it is vital Share XA blueprint for healthcare: Brand strategy and planninghttps://pharmaphorum.com/sales-marketing/a-blueprint-for-healthcare-brand-strategy-and-planning/
Breaking new ground in digital content delivery for pharmaIt’s all too easy for pharmaceutical processes to slow marketing campaigns, rendering them unmanageable and ineffective, but a Share XBreaking new ground in digital content delivery for pharmahttps://pharmaphorum.com/sales-marketing/breaking-new-ground-in-digital-content-delivery-for-pharma/
Good data supports pharma sales reps to drive lead generationAllow pharma sales reps to focus on the job in hand by making sure they have access to Share XGood data supports pharma sales reps to drive lead generationhttps://pharmaphorum.com/sales-marketing/good-data-supports-pharma-sales-reps-to-drive-lead-generation/
ASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trial Share XASCO 2019 – Kantar considers MacroGenics’ phase 3 SOPHIA trialhttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/kantar-macrogenics-phase-3-sophia-trial/
ASCO 2019 – phase I data generates hope for the future Share XASCO 2019 – phase I data generates hope for the futurehttps://pharmaphorum.com/spotlight/asco-2019-and-the-future-of-oncology/amgen-kras-amg510-phase-i-data/
ASCO 2019 – Enfortumab comes out fighting in bladder cancer Share XASCO 2019 – Enfortumab comes out fighting in bladder cancerhttps://pharmaphorum.com/video/asco-2019-enfortumab-bladder-cancer/
Piecing Together the KOL Puzzle Share XPiecing Together the KOL Puzzlehttps://pharmaphorum.com/partner-content/piecing-together-the-kol-puzzle/
Point-of-Care Ultrasound Market will cross $3,000 million by 2025 Share XPoint-of-Care Ultrasound Market will cross $3,000 million by 2025https://pharmaphorum.com/partner-content/point-of-care-ultrasound-market-will-cross-3000-million-by-2025/
World Biosimilars Market will surge at 27%+ CAGR up to 2025 Share XWorld Biosimilars Market will surge at 27%+ CAGR up to 2025https://pharmaphorum.com/partner-content/world-biosimilars-market-will-surge-at-27-cagr-up-to-2025/
Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019 Share XInvitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019https://pharmaphorum.com/partner-content/invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
